MM
Therapeutic Areas
Axplora Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ADC Payload Commercial Manufacturing | Oncology (Antibody-Drug Conjugates) | Commercial |
| GLP-1 Agonist Manufacturing Capacity Expansion | Metabolic Disorders (e.g., Diabetes, Obesity) | Commercial/Development |